Breaking News Instant updates and real-time market news.

CENT

Central Garden & Pet

$36.85

-0.82 (-2.18%)

, KR

Kroger

$29.19

-0.36 (-1.22%)

07:17
03/21/17
03/21
07:17
03/21/17
07:17

Telsey Advisory Group to hold a conference

9th Annual Spring Consumer Conference is being held in New York on March 21.

CENT

Central Garden & Pet

$36.85

-0.82 (-2.18%)

KR

Kroger

$29.19

-0.36 (-1.22%)

ANF

Abercrombie & Fitch

$11.67

-0.33 (-2.75%)

MNRO

Monro Muffler

$52.80

-1.55 (-2.85%)

  • 21

    Mar

  • 21

    Mar

  • 22

    Mar

  • 23

    Mar

  • 10

    Apr

  • 11

    Apr

  • 12

    Apr

  • 20

    Jun

CENT Central Garden & Pet
$36.85

-0.82 (-2.18%)

06/16/16
RHCO
06/16/16
UPGRADE
RHCO
Buy
Central Garden & Pet upgraded on stabilization, outlook at SunTrust
As noted earlier, SunTrust upgraded Central Garden & Pet to Buy from Neutral. The firm thinks that the company's business has stabilized, while the incoming CEO "can take the company to the next level." Target to $30 from $18.
06/16/16
RHCO
06/16/16
UPGRADE
RHCO
Buy
Central Garden & Pet upgraded to Buy from Neutral at SunTrust
KR Kroger
$29.19

-0.36 (-1.22%)

03/21/17
OPCO
03/21/17
NO CHANGE
OPCO
Perform
Oppenheimer expects Kroger, Whole Foods to be interested in Sprouts Farmers
Oppenheimer analyst Rupesh Parik notes Bloomberg reported that Albertsons and Sprouts Farmers Market (SFM) held preliminary merger talks with proposed plans to take the latter private. To the extent Sprouts Farmers Market is in play, the analyst would expect Kroger (KR) and Whole Foods (WFM) to also be interested. Further, Parik suspects a high $20-low $30 range would be a minimum to get a deal done, as industry valuations currently are depressed due in part to deflationary pressures. He reiterates a Perform rating on Sprouts Farmers Market's shares.
03/07/17
03/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Novartis (NVS) downgraded to Underperform from Neutral at Exane BNP Paribas. 2. Kroger (KR) downgraded to Neutral from Buy at Northcoast with analyst Chuck Cerankosky saying he sees little chance of earnings acceleration and or surprise over the next six months and is forecasting flat to slightly down operating earnings for fiscal 2017. 3. Casey's General Stores (CASY) downgraded to Sector Perform from Outperform at RBC Capital with analyst Irene Nattelciting the company's tepid third quarter report. 4. Diebold (DBD) downgraded to In-Line from Outperform at Imperial Capital with analyst Jeff Kessler saying the company's next four to six quarters are "likely to be characterized by a large and complex integration project for management." The analyst keeps a $30 price target for the shares. 5. Frontier Communications (FTR) downgraded to Neutral from Buy at BofA/Merrill with analyst David Barden saying the topline revenue has declined at a surprising rate, creating risk to the dividend. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/17
03/07/17
DOWNGRADE

Neutral
Kroger downgraded to Neutral on lack of earnings growth at Northcoast
As previously reported, Northcoast downgraded Kroger to Neutral from Buy. Analyst Chuck Cerankosky said he sees little chance of earnings acceleration and or surprise over the next six months and is forecasting flat to slightly down operating earnings for fiscal 2017.
03/07/17
NRCS
03/07/17
DOWNGRADE
NRCS
Neutral
Kroger downgraded to Neutral from Buy at Northcoast
ANF Abercrombie & Fitch
$11.67

-0.33 (-2.75%)

01/04/17
FBRC
01/04/17
UPGRADE
Target $13
FBRC
Market Perform
Abercrombie & Fitch upgraded to Market Perform from Underperform at FBR Capital
FBR Capital analyst Susan Anderson upgraded Abercrombie & Fitch to Market Perform with a slightly reduced price target of $13.
01/03/17
01/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Jefferies analyst Randal Konik downgraded Abercrombie & Fitch (ANF) to Hold saying the turnaround continues to struggle at the Abercrombie brand, with no visibility of a turnaround in sight. Also this morning, Oppenheimer analyst Anna Andreeva downgraded Abercrombie & Fitch to Underperform, saying consensus estimates have further downside as the brands "remain in transition amidst increasingly more competitive teen landscape." 2. Oppenheimer analyst Ittai Kidron downgraded Tableau (DATA) to Perform from Outperform to reflect the scope of near-term transition challenges integrating new leadership, the ratable shift, and competition, all hampering near-term upside potential. The analyst also cut Nokia's (NOK) rating to Perform from Outperform. 3. Piper Jaffray analyst Erinn Murphy downgraded Michael Kors (KORS) to Neutral saying the handbag category has been "highly promotional" while inventory levels have been high, particularly at department stores. The analyst sees no positive catalyst in the near-term for shares to re-rate higher and cut her price target for Kors to $48 from $60. 4. JPMorgan analyst Jimmy Bhullar downgraded Voya Financial (VOYA) to Underweight saying the risk/reward skews negative following the stock's outperformance in the second half of 2016. The analyst remains concerned about Voya's "subpar" return-on-equity. 5. JPMorgan analyst Michael Weinstein downgraded Medtronic (MDT) to Neutral saying the new macro environment of rising rates and a strengthening dollar will make it challenging for the shares to outperform in 2017. This morning Weinstein also downgraded Becton Dickinson (BDX) to Neutral saying the new macro environment of rising rates and a strengthening dollar will make it challenging for defensive growth names to outperform in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/03/17
WOLF
03/03/17
DOWNGRADE
WOLF
Underperform
Abercrombie & Fitch downgraded to Underperform at Wolfe Research
Wolfe Research downgraded Abercrombie & Fitch to Underperform from Peer Perform with a $10 price target citing low visibility into a comp turnaround, margin contraction, and a potentially unsustainable dividend yield.
01/04/17
FBRC
01/04/17
UPGRADE
Target $13
FBRC
Market Perform
FBR upgrades Abercrombie to Market Perform after selloff
FBR Capital analyst Susan Anderson upgraded Abercrombie & Fitch to Market Perform from Underperform citing the stock's 28% decline since her November 15, 2016 downgrade. Near-term negative results are likely priced into the stock, Anderson tells investors in a research note. She believes, however, that Abercrombie's same-store-sales will remain challenged driven by the A&F brand and Europe. The analyst lowered her price target for the shares to $13 from $14.
MNRO Monro Muffler
$52.80

-1.55 (-2.85%)

10/27/16
NRCS
10/27/16
UPGRADE
NRCS
Neutral
Monro Muffler upgraded to Neutral from Sell at Northcoast
Northcoast analyst Nick Mitchell upgraded Monro Muffler to Neutral saying risk/reward is balanced following the 19% pullback in shares since mid July.
01/26/17
OPCO
01/26/17
NO CHANGE
Target $70
OPCO
Outperform
Monro Muffler price target lowered to $70 from $80 at Oppenheimer
Oppenheimer analyst Brian Nagel lowered his price target for Monro Muffler to $70 from $80 on valuation. The analyst reiterates an Outperform rating on the shares as he is encouraged with indications of more conducive weather, all while nearer-term industry fundamentals are potentially improving and stepped-up acquisition activity is set to pay off.
01/31/17
GABE
01/31/17
UPGRADE
Target $76
GABE
Buy
Monro Muffler upgraded to Buy from Hold at Gabelli
Gabelli analyst Carolina Jolly upgraded Monro Muffler to Buy with a $76 price target citing valuation, acquisition growth, and a history of execution.
01/31/17
01/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Teva (TEVA) upgraded to Buy from Neutral at BofA/Merrill with analyst Sumant Kulkarni said the last night's unfavorable Court ruling is not a surprise and the company has already lowered its financial outlook on higher generic price erosion. Now that the ruling is out of the way, the analyst views Teva risk/reward as favorable and notes shares are down 58% since July 16, 2016 when it provided a more optimistic outlook. Over time, Kulkarni expects investors will be rewarded from Teva's leading generic pipeline and underappreciated brand pipeline. 2. CBOE Holdings (CBOE) upgraded to Buy from Underperform at BofA/Merrill with analyst Michael Carrier upgrading CBOE Holdings two notches to Buy from Underperform and raising its price target to $85 from $74. The analyst sees multiple sources of upside to accelerate earnings driven by the BATS deal, increased capital deployment, rising volatility off of historic lows, and potential US tax reform. 3. Monro Muffler (MNRO) upgraded to Buy from Hold at Gabelli with analyst Carolina Jolly citing valuation, acquisition growth, and a history of execution. 4. Tupperware Brands (TUP) upgraded to Neutral from Sell at B. Riley with analyst Linda Bolton Weiser increasing her price target for the shares to $54 from $47. 5. ViaSat (VSAT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Andrew Spinola saying the valuation is attractive for "strong" medium- and long-term growth from the Viasat-2 and Viasat-3 launches. The analyst expects EBITDA growth of 41% and 21% in fiscal 2019 and fiscal 2020, respectively. He raised his price target for the shares to $94-$98 from $76-$78. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

MRK

Merck

$64.16

0.375 (0.59%)

11:25
05/22/17
05/22
11:25
05/22/17
11:25
Hot Stocks
Merck says Phase 2 study results warrant continued evaluation of MK-7264 »

Merck announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

LC

LendingClub

$5.92

0.26 (4.59%)

, ONDK

On Deck Capital

$3.71

0.32 (9.44%)

11:23
05/22/17
05/22
11:23
05/22/17
11:23
Periodicals
Online lendeers attract bond buyers, WSJ says »

According to…

LC

LendingClub

$5.92

0.26 (4.59%)

ONDK

On Deck Capital

$3.71

0.32 (9.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

MGM

MGM Resorts

$31.66

0.41 (1.31%)

11:20
05/22/17
05/22
11:20
05/22/17
11:20
Options
Notable option blocks in MGM »

Notable option blocks in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
05/22/17
05/22
11:17
05/22/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
05/22/17
05/22
11:16
05/22/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTBC

Medical Transcription Billing

$1.90

0.02 (1.06%)

11:15
05/22/17
05/22
11:15
05/22/17
11:15
Hot Stocks
MTBC jumps after announcing releases of app for smartphones »

Earlier today, MTBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

XOM

Exxon Mobil

$82.08

0.147 (0.18%)

11:13
05/22/17
05/22
11:13
05/22/17
11:13
Hot Stocks
Exxon Mobil completes polyethylene lines at Texas plant »

ExxonMobil Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

XOP

SPDR Oil Exploration and Production Fund

$35.37

-0.15 (-0.42%)

11:10
05/22/17
05/22
11:10
05/22/17
11:10
Options
Upside call buying in SPDR Oil Exploration and Production ETF »

Upside call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
05/22/17
05/22
11:10
05/22/17
11:10
General news
Treasury announced a $55 B 4-week bill auction for Tuesday »

Treasury announced a $55…

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Orbotech sinks after disclosing criminal probe by Israel Tax Authority »

Orbotech earlier today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

AVY

Avery Dennison

$83.18

0.42 (0.51%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Avery Dennison acquires Finesse Medical »

Avery Dennison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Downgrade
Orbotech rating change  »

Orbotech downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RPT

Ramco-Gershenson

$12.75

-0.16 (-1.24%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Conference/Events
Ramco-Gershenson management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AVT

Avnet

$36.98

-0.1099 (-0.30%)

11:06
05/22/17
05/22
11:06
05/22/17
11:06
Hot Stocks
Avnet named exclusive global distributor for Silego Technology »

Avnet and Silego…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
05/22/17
05/22
11:05
05/22/17
11:05
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

RARX

RA Pharmaceuticals

$24.62

-0.32 (-1.28%)

11:04
05/22/17
05/22
11:04
05/22/17
11:04
Conference/Events
RA Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 25

    May

  • 22

    Jun

BBRY

BlackBerry

$10.38

0.27 (2.67%)

11:00
05/22/17
05/22
11:00
05/22/17
11:00
Options
Blackberry calls active as the rally continues »

Blackberry calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:58
05/22/17
05/22
10:58
05/22/17
10:58
Conference/Events
Quotient Technology management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Conference/Events
Quotient Technology management to meet with Loop »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

RHHBY

Roche

$34.30

0.495 (1.46%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Hot Stocks
FDA approves Roche's Actemra for giant cell arteritis »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

  • 26

    Jun

PQ

PetroQuest

$2.42

0.1285 (5.61%)

10:56
05/22/17
05/22
10:56
05/22/17
10:56
Conference/Events
PetroQuest management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 25

    May

C

Citi

$60.95

-0.15 (-0.25%)

10:53
05/22/17
05/22
10:53
05/22/17
10:53
Hot Stocks
Citi releases statement on settlement with DOJ over BUSA »

Citi issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 25

    Jul

PLNT

Planet Fitness

$20.81

0.13 (0.63%)

10:51
05/22/17
05/22
10:51
05/22/17
10:51
Conference/Events
Planet Fitness management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.